Genetic Risk Score and SNPs to predict semaglutide and tirzepatide weight loss response in adults with obesity
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
Abstract
A prospective cohort study will investigate if Genetic Risk Scores and SNPs can predict semaglutide or tirzepatide weight loss response in adults with obesity.